Scalper1 News
Fallen former IBD 50 stock Salix Pharmaceuticals (SLXP) seemed to be getting some investor credibility back Tuesday as the company said it would clear up its inventory problems earlier than expected and offered 2015 and 2016 guidance that pointed to accelerating growth. Salix stock jumped 9% in early trading in the stock market today, near 112. Last month, Salix shocked Wall Street on its Q3 earnings report by announcing the resignation of its CFO Scalper1 News
Scalper1 News